Recent advances in carcinoid pathogenesis, diagnosis and management

Area of Science:

• Oncology
• Molecular Biology
• Medical Imaging

Background:

• Carcinoid tumors present diagnostic challenges due to nonspecific symptoms.
• Molecular biology advances offer insights into tumor aggressiveness and pathogenesis.
• Carcinoid heart disease requires further investigation into its molecular basis.

Purpose of the Study:

• To review recent advances in the diagnosis and management of carcinoid tumors.
• To highlight the role of molecular markers and advanced imaging techniques.
• To discuss the efficacy of somatostatin analogues in carcinoid syndrome treatment.

Main Methods:

• Review of molecular biology research on carcinoid tumor aggressiveness.
• Evaluation of somatostatin receptor scintigraphy (SRS) and positron emission tomography (PET) for tumor localization.
• Analysis of the clinical application of long-acting somatostatin analogues.

Main Results:

• Molecular markers are improving the understanding of carcinoid tumor behavior.
• SRS and PET offer enhanced sensitivity for detecting primary and metastatic carcinoid tumors.
• Somatostatin analogues are effective and convenient for managing carcinoid syndrome, potentially suppressing tumor growth.

Conclusions:

• Recent advancements in molecular biology and imaging have significantly improved carcinoid tumor diagnosis and localization.
• Long-acting somatostatin analogues provide an effective therapeutic option for carcinoid syndrome with potential anti-tumor effects.
• Further research into molecular pathogenesis is crucial for advancing carcinoid tumor and carcinoid heart disease treatment.